Table: Sawai Pharmaceutical -2015/16 group results

SAWAI group

12/05/2016 07:00

May 12 (Reuters)-  
          Sawai Pharmaceutical Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to       NEXT    
                Mar 31, 2016    Mar 31, 2015   Mar 31, 2017     YEAR      
                   LATEST         YEAR-AGO        COMPANY      COMPANY    
                   RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales            123.49          105.45         143.00        69.70     
                 (+17.1 pct)     (+17.4 pct)    (+15.8 pct)  (+18.2 pct)  
  Operating         23.19           20.69          25.00        12.20     
                 (+12.1 pct)     (+8.4 pct)     (+7.8 pct)    (+5.1 pct)  
  Recurring         23.03           20.62          24.70        12.00     
                 (+11.7 pct)     (+8.0 pct)     (+7.3 pct)    (+4.9 pct)  
  Net 
  Net               17.16           14.05          18.50         8.70     
                 (+22.1 pct)     (+15.3 pct)    (+7.8 pct)    (+2.4 pct)  
  EPS            465.57 yen      382.26 yen     502.05 yen    236.10 yen  
  EPS Diluted    465.25 yen      381.85 yen                               
  Ann Div        120.00 yen      105.00 yen     130.00 yen                
  -Q2 Div         55.00 yen       50.00 yen      65.00 yen                
  -Q4 Div         65.00 yen       55.00 yen      65.00 yen                
   
  NOTE - Sawai Pharmaceutical Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T 
  ((Tokyo Headline News Desk +813 6441 1812))